About Straumann Holding AG

Company Description

We are a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann conducts research, develops and manufactures dental implants, instruments, prosthetics, tissue and bone regeneration biomaterials for use in tooth replacement and restoration, or to prevent tooth loss. Technological advancements are changing dentistry fundamentally. Straumann offers a broad range of products and solutions for both conventional treatment and digital workflows including guided surgery, intra-oral scanning and CAD/CAM restorations.

We share your passion for quality and desire to achieve the best patient outcomes. Groundbreaking and evidence-based innovations are not the only reasons why you can enjoy peace of mind with us. Our highly skilled and motivated team has more than 60 years of experience in business partnering, training and education, and is dedicated to providing global support.

Year founded

1954

Served area

Worldwide

Headcount

9,000

Headquarters

Peter Merian-Weg 12, 4002 Basel – Switzerland

Shareholder information

Shares outstanding

159,213,690

IPO

June 2, 1998

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.